Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
- Resource Type
- Article
- Source
- In
Annals of Oncology January 2010 21(1):61-66 - Subject
- Language
- ISSN
- 0923-7534